A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per...

Abstract

Treatment with indinavir, zidovudine, and lamivudine as compared with zidovudine and lamivudine alone significantly slows the progression of HIV-1 disease in patients with 200 CD4 cells or fewer per cubic millimeter and prior exposure to zidovudine.

Keywords

IndinavirLamivudineZidovudineMedicineHazard ratioVirologyStavudineInternal medicineRegimenProtease inhibitor (pharmacology)GastroenterologySidaConfidence intervalImmunologyViral loadViral diseaseVirus

Affiliated Institutions

Related Publications

Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors

Zhenming Jin , Xiaoyu Du , Yechun Xu +28 more

2020 Nature 4341 citations

Decline in deaths from AIDS due to new antiretrovirals

Robert S. Hogg , Michael V. O’Shaughnessy , Nada Gataric +4 more

1997 The Lancet 377 citations

Monitoring Plasma HIV-1 RNA Levels in Addition to CD4+ Lymphocyte Count Improves Assessment of Antiretroviral Therapeutic Response

Michael D. Hughes

For an individual patient, a change in plasma HIV-1 RNA level of 2.5-fold or more probably indicates a true biological change. Monitoring HIV-1 RNA levels and CD4+ lymphocytes b...

1997 Annals of Internal Medicine 282 citations

Nevirapine, Zidovudine, and Didanosine Compared with Zidovudine and Didanosine in Patients with HIV-1 Infection

Richard T. D’Aquila

Adding nevirapine to zidovudine and didanosine improved the long-term immunologic and virologic effects of therapy and was associated with severe rash among the patients studied...

1996 Annals of Internal Medicine 291 citations

Lamivudine Plus Zidovudine Compared with Zalcitabine Plus Zidovudine in Patients with HIV Infection

John Bartlett

In patients with HIV infection who had previously received zidovudine, 150 mg of lamivudine plus zidovudine resulted in greater immunologic evidence of benefit than did 0.75 mg ...

1996 Annals of Internal Medicine 110 citations

Publication Info

Year: 1997
Type: article
Volume: 337
Issue: 11
Pages: 725-733
Citations: 2664
Access: Closed

External Links

View on DOI.org

Social Impact

Altmetric

A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less

PlumX Metrics

Social media, news, blog, policy document mentions

Citation Metrics

2664

OpenAlex

Cite This

APA Style

                            
                                
                                    Scott M. Hammer, 
                                
                                    Kathleen Squires, 
                                
                                    Michael D. Hughes
                                
                                et al.
                            
                            (1997). 
                            A Controlled Trial of Two Nucleoside Analogues plus Indinavir in Persons with Human Immunodeficiency Virus Infection and CD4 Cell Counts of 200 per Cubic Millimeter or Less. 
                            New England Journal of Medicine
                            , 337
                            (11)
                            , 725-733.
                            https://doi.org/10.1056/nejm199709113371101
                        

Identifiers

DOI: 10.1056/nejm199709113371101